Express Scripts Holding PE Ratio 2006-2018 | ESRX

Current and historical price to earnings ratio for Express Scripts Holding (ESRX) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Express Scripts Holding PE ratio as of September 20, 2018 is 11.76.
Express Scripts Holding Annual PE Ratio
Express Scripts Holding Quarterly PE Ratio
Sector Industry Market Cap Revenue
Medical Medical Services $53.199B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.940B 25.71
PRA Health Sciences (PRAH) United States $6.922B 30.20
Charles River Laboratories (CRL) United States $6.141B 22.43
HealthEquity (HQY) United States $5.731B 119.95
Premier (PINC) United States $5.690B 20.50
Teladoc (TDOC) United States $5.247B 0.00
INC Research Holdings (SYNH) United States $4.913B 21.80
NovoCure (NVCR) Jersey $4.831B 0.00
AMN Healthcare Services Inc (AMN) United States $2.408B 18.50
Medpace Holdings (MEDP) United States $2.052B 28.84
BioTelemetry (BEAT) United States $1.976B 45.30
Intrexon (XON) United States $1.855B 0.00
Natera (NTRA) United States $1.432B 0.00
Healthways (TVTY) United States $1.348B 19.04
IKang Healthcare (KANG) China $1.167B 64.65
CareDx (CDNA) United States $0.940B 0.00
China Cord Blood (CO) China $0.785B 21.00
Surgery Partners (SGRY) United States $0.768B 0.00
Apollo Medical Holdings (AMEH) United States $0.547B 0.00
Civitas Solutions (CIVI) United States $0.525B 10.36
Establishment Labs Holdings (ESTA) $0.491B 0.00
OncoCyte (OCX) United States $0.098B 0.00
Interpace Diagnostics (IDXG) United States $0.047B 0.00
Cancer Genetics (CGIX) United States $0.030B 0.00
OpGen (OPGN) United States $0.012B 0.00
Biocept (BIOC) United States $0.007B 0.00
FORM Holdings (XSPA) United States $0.004B 0.00